Christopher Coe
@CCoeMD
Followers
194
Following
87
Media
3
Statuses
43
Transplant Hepatology fellow at MedStar Georgetown. Views are my own.
Los Angeles, CA
Joined April 2010
📢Check out the winning #HepMadness summary by @drmuaazmasood on bridging the gaps in guideline directed care! LNF clinical pearl content writer @SarahUttal won🥇for her bracket submission—winning a free @AASLDtweets post-grad course! Join the fun of #HepMadness next fall!
Mind the Gap! Check out @drmuaazmasood summary of 4⃣ 🔑 articles about bridging gaps in guideline-directed hepatology care. How will you use these @HepCommJournal 📜 to improve outcomes in your own hepatology practice?🤔 #HepMadness #Livertwitter #MedEd
https://t.co/vt5ltW2LF8
0
7
15
Happening in 6 minutes! Come support our fabulous trainees and see what LFN has to offer!
📢All trainees and #MedEd enthusiasts! ❓Where are you going to be at 11 am today? 📍Ballroom 6C for “The best of Liver Fellow Network” Learn with us and support our fantastic content writers 👏👏👏
2
2
13
We are extending HepMadness deadline until tomorrow! Be sure to play and potentially win fantastic prizes! See below for how to play!⬇️
Today’s a great day to submit your #hepmadness bracket! Here’s how: 1) follow this link: https://t.co/M3IBgbSRUZ 2) sign up (takes 30 seconds) 3) fill out your bracket and get awesome summaries of the latest and greatest hep research from @HepCommJournal and @LTxJournal
0
6
6
Living donors & split🔪 livers are crucial for addressing the shortage of available livers for transplantation. Learn more in this post by @s_taranika summarizing 5⃣ 📜 in @LTxJournal
#HepMadness #livertwitter #GItwitter #MedEd Fill out your bracket 👇 https://t.co/bUctZdpQWo
2
8
20
Should we start rx’ing statins stat? 💊 @crlopez92 breaks down 3 key articles in HepComm for us. See her post below, and let us know: did you pass out atorvastatin for your hepatology patients this Halloween?🎃 #Hepmadness #livertwitter #FOAMed #MedEd
https://t.co/bUctZdpQWo
1
13
40
🚨🚨GI/hep fellows studying for boards!🚨🚨🚨 ⬇️76 hepatology practice questions now available thanks to @AASLDtweets & @LiverFellow
https://t.co/yT4VjmigVe 👏 👏👏Major kudos to fellow authors & faculty editor Matt Odenwald! #livertwitter #gitwitter #meded
2
25
68
Today’s a great day to submit your #hepmadness bracket! Here’s how: 1) follow this link: https://t.co/M3IBgbSRUZ 2) sign up (takes 30 seconds) 3) fill out your bracket and get awesome summaries of the latest and greatest hep research from @HepCommJournal and @LTxJournal
1
5
10
You are invited to play HepMadness Brought to you by @LiverFellow Fill out a bracket: https://t.co/lYIty5rH1w Pick your winners amongst the hottest topics in all of liverland and, maybe, win a prize Inspired by work published in @LTxJournal and @HepCommJournal
1
17
29
🤖Rise of the machines! Machines have undoubtedly transformed liver transplantation and can expand our donor pool, but can be associated with 📈 complications. Check out this great summary @sanad_dawod of 5️⃣ recent 📝! #HepMadness #livertwitter #MedEd
https://t.co/bUctZdpQWo
2
10
30
Great job, Sanad! Check out this post on “rise of the machines” in @LTxJournal! Also, be sure to fill out your #HepMadness bracket!👇 https://t.co/bUctZdpQWo
#HepMadness is here! Check out my entry! Had so much fun learning about the different available technologies that will allow us to expand access to transplant! @LTxJournal @AASLDtweets #livertwitter #GITwitter
0
2
12
Mind the Gap! Check out @drmuaazmasood summary of 4⃣ 🔑 articles about bridging gaps in guideline-directed hepatology care. How will you use these @HepCommJournal 📜 to improve outcomes in your own hepatology practice?🤔 #HepMadness #Livertwitter #MedEd
https://t.co/vt5ltW2LF8
1
7
19
🏥The circle-based allocation system was designed to better comply with the Final Rule (🩺 urgency > 🌎 )...but has it? Dive into these 4⃣@LTxJournal 📜to explore ongoing inequities, benefits of standardization, and more! @AnjanaRajanMD #HepMadness #MedEd
https://t.co/vt5ltW2LF8
2
6
15
Hmm...👨⚕️👩⚕️providers & patients aren’t 🗣️ about 🍷🍸enough, even though 🍺🍹 leads to progression of liver disease. 🤔Check out this evidence summary ✍️ by Mary McGrath on how this care gap ➡️ poor outcomes. #HepMadness #livertwitter #MedEd 🗳️✅Bracket👇: https://t.co/vt5ltW2LF8
1
9
22
‼️#HepMadness is here‼️ What: NCAA-style bracket competition: @HepCommJournal vs. @LTxJournal Who: You! Where: Follow on #LiverTwitter/X, 🥇🥈🥉 to be announced at #TLM24 How: Read the posts ➕ fill out your bracket by 11/11, full instructions 👇 https://t.co/vt5ltW2LF8
0
13
21
So grateful to @ArpanPatelMD for his mentorship and guidance! Proud to present our QI project: Pilot testing a novel AUD curriculum for GI Fellows at @UCLAGIHep
3
4
15
Development & Pilot Testing of a Novel Alcohol Use Disorder Training Program for GI Fellows 🙌Christopher L. Coe, MD (@CCoeMD) 👥 @_DavidLawrence7 @JBenhammouMD @TienDongMD @JulioMe74531224 @ponnivp @jasleensinghmd @LinChangMD @ArpanPatelMD et al ⏰#DDW2024 May 19, 12:30 pm
0
5
11
Welcome to the UCLA GI Fellowship family!
🙌Look who's joining #UCLAGI! We are thrilled & know you will thrive under the mentorship of @LinChangMD 🌟Preetha Iyengar 🌟Bryan Kim @bryan_jkim 🌟Sagar "Arnie" Shah @ArnieShahMD 🌟Brandon Smith @BrandonCSmithMD 🌟Ellen Spartz 🌟Farnoosh Vahedi 🌟Sigrid Young @SigridYoungMD
0
0
10
📢Terlipressin & CCM by POCUS 🌟CCM & its echo markers associated w ⬆️ risk of non-response to Terlipressin 🌟 CCM predicts mortality in HRS-AKI 🌟 Patients with CCM on Terlipressin may be at ⬆️risk of pulm edema #CCM @HEP_Journal
@docMPK leading the way in POCUS in Cirrhosis
Continuing terli series and POCUS- CCM & terli non-response predicts mortality @HEP_Journal Congratulations @docMPK @manhalizzy Dr Kamal Kajal. @AsraniSumeet @acv69cardenas @JuanAbraldes
2
10
36
Great results from the first clinical trial testing NALTREXONE vs placebo in alcohol-related cirrhosis, today at #TLM23 : 🔸Naltrexone is well tolerated 🔸It favors abstinence 🔸It reduces by 50% new onset decompensation @AASLDtweets #livertwitter #MedTwitter @ILBS_India
8
77
227